Greiner Bio-One International GmbH

Company Snapshot

Founded: 1963
Entity Type: Private
Region: Austria
Headquarter: Kremsmünster, Austria
Key Geographics: North America, Europe, Asia, South America
Corporate Address: Bad Haller Street 32 A-4550 Kremsmünster Austria Tel. +43-(0)-7583-6791-0 www.gbo.com

Company Overview

Greiner Bio-One, a global leader in biotechnology, diagnostics, and medical devices, offers solutions through its 28 subsidiaries worldwide having presence in every region. With over 2,300 employees, they provide tailored solutions to meet specific needs, ensuring quality, innovation, and customer satisfaction in their products and services.

Greiner Bio-One is supporting a groundbreaking collaboration between Scripps Florida, Cold Spring Harbor Laboratory, and Nano3D Biosciences Inc. This NIH-funded project aims to accelerate cancer drug discovery by developing automated, high-throughput 3D spheroid screening technologies.

Greiner Bio-One International GmbH In Reports

Laboratory Animal Models, 3D Cultures, and Organoids: Global Markets

BCC Research Market Analyst says global market for laboratory animal models, 3D cultures, and organoids is estimated to increase from $2.8 billion in 2024 to reach $5.0 billion by 2029.

3D Cell Cultures: Technologies and Global Markets

BCC Research Market Analyst says global market for 3D cell culture is estimated to increase from $4.6 billion in 2023 to reach $14.8 billion by 2028 at a CAGR of 26.5% from 2023 through 2028.

Circulating Tumor Cell (CTC) Diagnostics: Technologies and Global Markets

BCC Research Market Report for Circulating Tumor Cell (CTC) Diagnostics. Global CTC Diagnostics Technologies market trends, with CAGRs through 2026.

Company's Business Segments

  • Preanalytics : This segment develops and manufactures systems for taking blood and urine samples from people and animals. 
  • Mediscan : This segment supplies and offers services in sterilizing medical products, food packaging, and the functional improvement of plastics and semiconductors using ionizing radiation.
  • BioScience : This segment focuses on developing and manufacturing laboratory equipment, such as containers for cultivating and analyzing cell cultures and microplates for high-throughput screening in biochemical, genetic, and pharmacological tests.

Applications/End User Industries

  • Laboratories
  • Hospitals
  • Research facilities
  • Pharmaceutical Industries
AI Sentiment